RxDoctor Payments Data

Blaine Carmichael, PA

Physician Assistant · Seguin, TXNPI 1386633121

Payments from drug & device makers

$15,754in general payments, 2019–2025

Across 202 payments — averaging $77.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$14K
  • Novo Nordisk$276
  • Bayer$215
  • Biohaven Pharmaceuticals, Inc.$138
  • AstraZeneca$136
  • Lilly USA, LLC$110
  • plus $657 from 12 others

What the payments were for

  • Speaking & faculty fees$12,68180%
  • Travel & lodging$1891%
  • Food & beverage$2,88518%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$15,754 in reported general payments places this provider in the 95th percentile of 8,308 physician assistant providers in Texas.

See all physician assistant providers in Texas

Medicare billing

Part B allowed, 2024
$26,333
Medicare patients
178
Services billed
445

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide17$26,642
Trelegy ElliptaFluticasone/Umeclidin/Vilanter20$21,468
FarxigaDapagliflozin Propanediol11$16,470
EliquisApixaban11$13,905
Breztri AerosphereBudesonide/Glycopyr/Formoterol12$11,053
Atorvastatin Calcium131$1,355
Metoprolol Succinate77$1,246
Rosuvastatin Calcium86$1,161
Gabapentin53$1,082
Albuterol Sulfate HfaAlbuterol Sulfate44$1,051
Levothyroxine Sodium102$943
Tizanidine Hcl19$862
Omeprazole72$814
Famotidine24$756
Nabumetone33$743

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga, Breztri Aerosphere$136$27,52323 claims
Novo NordiskOzempic$276$26,64217 claims
GSKTrelegy Ellipta$106$21,46820 claims
PfizerEliquis$44$13,90511 claims
AbbVieSynthroid$14,223$30814 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 8,308 physician assistant providers in Texas.

Other physician assistant in Seguin

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →